Xingwei Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xingwei Ding has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Xiaolei Wang
School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, P. R. China
6 shared publications Hong-Bo Xin
Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
3 shared publicationsJun Li
3 shared publications- Kaiyong Cai
Key Laboratory of Biorheological Science and Technology Ministry of Education College of Bioengineering Chongqing University Chongqing China
3 shared publications Xueyin Jiang
Department of Materials Science, Shanghai University, Shanghai, China
3 shared publicationsZhilin Zhang
Key Laboratory of Advanced Display and System Application, Ministry of Education, Shanghai University, Shanghai, China
3 shared publications
Latest Publications
- 30 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (31) , 42305-42322
Cascade-Therapeutic Nanozyme Hydrogel Mediates Hypoxia Alleviation and Angiogenesis Promotion To Accelerate Diabetic Wound Healing
Diabetic wounds exhibit prolonged inflammation and excessive oxidative stress, impairing tissue repair. Chronic hypoxia arises from vascular dysfunction and metabolic dysregulation, creating a pathological cycle of oxidative damage, defective angiogenesis, and persistent inflammation. To address these challenges, we develop the multifunctional rosmarinic acid-cerium nanozyme (RA-Ce NP) hydrogel composites designed for diabetic wound therapy. The system integrates RA-Ce NPs, phenylboronic acid-grafted poly-l-lysine, and oxidized hyaluronic acid into a dynamically crosslinked hydrogel network through Schiff base and boronate ester linkages. Both in vitro and in vivo studies demonstrate that the hydrogel enables multienzyme mimicry for synergistic reactive oxygen species scavenging, controlled oxygen generation to relieve tissue hypoxia, and promotion of neovascularization. Our work provides a clinically translatable platform for diabetic wound therapy, offering antibacterial, anti-inflammatory, and angiogenesis-promoting functions.
- 30 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (31) , 42305-42322
Cascade-Therapeutic Nanozyme Hydrogel Mediates Hypoxia Alleviation and Angiogenesis Promotion To Accelerate Diabetic Wound Healing
Diabetic wounds exhibit prolonged inflammation and excessive oxidative stress, impairing tissue repair. Chronic hypoxia arises from vascular dysfunction and metabolic dysregulation, creating a pathological cycle of oxidative damage, defective angiogenesis, and persistent inflammation. To address these challenges, we develop the multifunctional rosmarinic acid-cerium nanozyme (RA-Ce NP) hydrogel composites designed for diabetic wound therapy. The system integrates RA-Ce NPs, phenylboronic acid-grafted poly-l-lysine, and oxidized hyaluronic acid into a dynamically crosslinked hydrogel network through Schiff base and boronate ester linkages. Both in vitro and in vivo studies demonstrate that the hydrogel enables multienzyme mimicry for synergistic reactive oxygen species scavenging, controlled oxygen generation to relieve tissue hypoxia, and promotion of neovascularization. Our work provides a clinically translatable platform for diabetic wound therapy, offering antibacterial, anti-inflammatory, and angiogenesis-promoting functions.
- 25 December 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 683 (Pt 2) , 357-371
An antibacterial and antioxidant rosmarinic acid hydrogel normalizes macrophage polarization to expedite diabetic wound healing
- 25 December 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 683 (Pt 2) , 357-371
An antibacterial and antioxidant rosmarinic acid hydrogel normalizes macrophage polarization to expedite diabetic wound healing
- 29 November 2024
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 7 (23) , 27400-27407
Hypoxia-Responsive Self-Assembling Nanoparticles Based on an Amphiphilic Copolymer for Targeted Delivery of Tissue Plasminogen Activator in Acute Mesenteric Ischemia Therapy
- 29 November 2024
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 7 (23) , 27400-27407
Hypoxia-Responsive Self-Assembling Nanoparticles Based on an Amphiphilic Copolymer for Targeted Delivery of Tissue Plasminogen Activator in Acute Mesenteric Ischemia Therapy
- 4 September 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (40) , 6099-6108
A magnetically modified black phosphorus nanosheet-based heparin delivery platform for preventing DVT accurately
A new heparin targeting delivery platform was developed based on iron oxide (Fe3O4) nanoparticles and polyethyleneimine (PEI) functionalized black phosphorus nanosheets (BP NSs).
- 4 September 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (40) , 6099-6108
A magnetically modified black phosphorus nanosheet-based heparin delivery platform for preventing DVT accurately
A new heparin targeting delivery platform was developed based on iron oxide (Fe3O4) nanoparticles and polyethyleneimine (PEI) functionalized black phosphorus nanosheets (BP NSs).
- 16 May 2019
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 46 (05) , 587-591
Shear-, Sound-, and Light-Sensitive Nanoparticles for Thrombolytic Drug Delivery
Thrombotic diseases, as potentially induced by blood clots or vascular embolization, frequently occur with high rates of mortalities worldwide. Current drug thrombolysis, a primary clinical therapy, may increase fatal risk of hemorrhage when thrombolysis agents become systemically distributed. Given current thrombolysis limitations, some novel drug delivery systems based on nanoparticles have been recently exploited to achieve a more controlled release of loaded thrombolytic agents, able to respond to environmental changes, and resulting in a safer thrombolysis. In this review, the authors outline and discuss some prominent examples of early and recent thrombolytic agent delivery systems using controlled release by physical stimuli (shear, sound and light). Shear-sensitive systems are designed to exploit the specific biomechanical feature of thrombosis, that is, the increased blood shear stress. Sound- and light-sensitive systems reflect “remote control” of drug release by responding to external ultrasound or light stimulus. These smart thrombolytic drug delivery systems hold promise for more effective and safer future thrombolytic therapy.
- 16 May 2019
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 46 (05) , 587-591
Shear-, Sound-, and Light-Sensitive Nanoparticles for Thrombolytic Drug Delivery
Thrombotic diseases, as potentially induced by blood clots or vascular embolization, frequently occur with high rates of mortalities worldwide. Current drug thrombolysis, a primary clinical therapy, may increase fatal risk of hemorrhage when thrombolysis agents become systemically distributed. Given current thrombolysis limitations, some novel drug delivery systems based on nanoparticles have been recently exploited to achieve a more controlled release of loaded thrombolytic agents, able to respond to environmental changes, and resulting in a safer thrombolysis. In this review, the authors outline and discuss some prominent examples of early and recent thrombolytic agent delivery systems using controlled release by physical stimuli (shear, sound and light). Shear-sensitive systems are designed to exploit the specific biomechanical feature of thrombosis, that is, the increased blood shear stress. Sound- and light-sensitive systems reflect “remote control” of drug release by responding to external ultrasound or light stimulus. These smart thrombolytic drug delivery systems hold promise for more effective and safer future thrombolytic therapy.
- 20 December 2018
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (2) , 1951-1956
Localized Light-Au-Hyperthermia Treatment for Precise, Rapid, and Drug-Free Blood Clot Lysis
Thrombus diseases, induced by blood stasis or vascular embolization normally, are frequently occurred with high disability and mortalities worldwide. At current state, drug thrombolysis, a primary clinical therapy for blood clot lysis, could increase lethal risk for hemorrhage when thrombolysis agents are over-used in the whole body. Therefore, a novel and advanced therapy for blood clot lysis, based on the remoted physical signals, is helpful for assisting clinical therapy. Here, we used the localized light-Au-hyperthermia (LAH) treatment, induced by gold nanorods (Au NRs) irradiated with near-infrared light (808 nm), for precise, rapid and drug-free blood clot lysis. The LAH technology was firstly introduced in murine hematoma model and murine myocardial infarction model for blood clot lysis. Compared with traditional therapy, LAH was assured to shorten the time of detumescence in murine hematoma model owning to their precise and localized hyperthermia. Meanwhile, we also discovered that the LAH was benefit to vascular recanalization in murine myocardial infarction model. In addition, the Au NRs used in the LAH present ideal biocompatiability in murine model, which endows it to be suitable for blood clot lysis in vivo.
- 20 December 2018
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (2) , 1951-1956
Localized Light-Au-Hyperthermia Treatment for Precise, Rapid, and Drug-Free Blood Clot Lysis
Thrombus diseases, induced by blood stasis or vascular embolization normally, are frequently occurred with high disability and mortalities worldwide. At current state, drug thrombolysis, a primary clinical therapy for blood clot lysis, could increase lethal risk for hemorrhage when thrombolysis agents are over-used in the whole body. Therefore, a novel and advanced therapy for blood clot lysis, based on the remoted physical signals, is helpful for assisting clinical therapy. Here, we used the localized light-Au-hyperthermia (LAH) treatment, induced by gold nanorods (Au NRs) irradiated with near-infrared light (808 nm), for precise, rapid and drug-free blood clot lysis. The LAH technology was firstly introduced in murine hematoma model and murine myocardial infarction model for blood clot lysis. Compared with traditional therapy, LAH was assured to shorten the time of detumescence in murine hematoma model owning to their precise and localized hyperthermia. Meanwhile, we also discovered that the LAH was benefit to vascular recanalization in murine myocardial infarction model. In addition, the Au NRs used in the LAH present ideal biocompatiability in murine model, which endows it to be suitable for blood clot lysis in vivo.
- 12 November 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (12) , 4219-4224
Platelet-Mimic uPA Delivery Nanovectors Based on Au Rods for Thrombus Targeting and Treatment
Systemic thrombolytic drugs administration always gained an unideal therapeutic effect due to the rapid neutralization by their antidotes. It is significant to seek an approach for targeted thrombolytic drugs delivery to thrombus. Here, a biocompatible, thrombus-targeted and low-cost platelet-mimic nanovector was fabricated to accomplish a sustained urokinase plasminogen activators (uPA) release at thrombus site. The prepared system presented a sustained model drug release behavior for 30 h and burst release behavior under near-infrared laser irradiation with a hyperthermia in vitro. We demonstrate that the fabricated nanovectors can arrive and aggregate at pulmonary thrombus, followed by a sustained uPA release in murine pulmonary embolism model. Therefore, according to the results, the formulated nanovector presented a hopeful application for targeted thrombolytic therapy clinically.
- 12 November 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (12) , 4219-4224
Platelet-Mimic uPA Delivery Nanovectors Based on Au Rods for Thrombus Targeting and Treatment
Systemic thrombolytic drugs administration always gained an unideal therapeutic effect due to the rapid neutralization by their antidotes. It is significant to seek an approach for targeted thrombolytic drugs delivery to thrombus. Here, a biocompatible, thrombus-targeted and low-cost platelet-mimic nanovector was fabricated to accomplish a sustained urokinase plasminogen activators (uPA) release at thrombus site. The prepared system presented a sustained model drug release behavior for 30 h and burst release behavior under near-infrared laser irradiation with a hyperthermia in vitro. We demonstrate that the fabricated nanovectors can arrive and aggregate at pulmonary thrombus, followed by a sustained uPA release in murine pulmonary embolism model. Therefore, according to the results, the formulated nanovector presented a hopeful application for targeted thrombolytic therapy clinically.
- 11 October 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (12) , 4331-4337
Microstructural Orientation and Precise Regeneration: A Proof-of-Concept Study on the Sugar-Cane-Derived Implants with Bone-Mimetic Hierarchical Structure
It is of great importance to develop a 3D scaffold that matches the bone in the aspect of element and structure. In order to achieve this aim, the sugarcane aerogels derived borate glasses scaffolds were developed through in situ bio-glass modification. Sol–gel derived borate glasses of the 30-5B (Si/B ratio) composition have been prepared to produce 3D borate scaffolds with sugarcane morphologies. As a result, not only the elemental distribution but also the multi-level structure of this Gramineae plant derived implants were remarkably matched with natural bone. The subsequent animal implantation experiment found that the microstructural orientation of the implant had an important impact on the result of bone repair. The relative mechanisms were also discussed for the first time.
- 11 October 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (12) , 4331-4337
Microstructural Orientation and Precise Regeneration: A Proof-of-Concept Study on the Sugar-Cane-Derived Implants with Bone-Mimetic Hierarchical Structure
It is of great importance to develop a 3D scaffold that matches the bone in the aspect of element and structure. In order to achieve this aim, the sugarcane aerogels derived borate glasses scaffolds were developed through in situ bio-glass modification. Sol–gel derived borate glasses of the 30-5B (Si/B ratio) composition have been prepared to produce 3D borate scaffolds with sugarcane morphologies. As a result, not only the elemental distribution but also the multi-level structure of this Gramineae plant derived implants were remarkably matched with natural bone. The subsequent animal implantation experiment found that the microstructural orientation of the implant had an important impact on the result of bone repair. The relative mechanisms were also discussed for the first time.
- 25 August 2017
- Published by Wiley in Advanced Functional Materials
- Vol. 27 (40)
Near‐Infrared Triggered Release of uPA from Nanospheres for Localized Hyperthermia‐Enhanced Thrombolysis
Currently, most thrombolytic agents are limited by short circulation time and excessive dose needed for clinical therapy, which increases lethal risk for intracranial hemorrhage. Here, a near‐infrared‐triggered, controlled‐release system, using gold@mesoporous silica core–shell nanospheres (Au@MSNs) with phase‐changed material 1‐tetradecanol, is formulated to release urokinase plasminogen activators (uPA) on demand. The prepared system presents a sensitive system for releasing uPA, owing to an elevated temperature created by Au@MSNs‐induced photothermal effect. For in vitro study, a 3D printed vein vasculature is designed and fabricated to simulate the thrombolysis of system in blood vessel. Murine tail thrombus model is also built to evaluate thrombolysis in vivo. Consequently, localized hyperthermia is validated to possess an effective enhancement for thrombolysis. Therefore, according to the results, the fabricated system demonstrates two aspects of potential superiority: controlled uPA release for reducing risk of side effects, and hyperthermia‐enhanced thrombolysis locally for decreasing drug dosage. Assisted with thermal thrombolysis, the present formulated system shows a high efficiency, on‐demand drug release, and thus a safer protocol for thrombolytic therapy, which fits the developing trends of precision medicine.
- 25 August 2017
- Published by Wiley in Advanced Functional Materials
- Vol. 27 (40)
Near‐Infrared Triggered Release of uPA from Nanospheres for Localized Hyperthermia‐Enhanced Thrombolysis
Currently, most thrombolytic agents are limited by short circulation time and excessive dose needed for clinical therapy, which increases lethal risk for intracranial hemorrhage. Here, a near‐infrared‐triggered, controlled‐release system, using gold@mesoporous silica core–shell nanospheres (Au@MSNs) with phase‐changed material 1‐tetradecanol, is formulated to release urokinase plasminogen activators (uPA) on demand. The prepared system presents a sensitive system for releasing uPA, owing to an elevated temperature created by Au@MSNs‐induced photothermal effect. For in vitro study, a 3D printed vein vasculature is designed and fabricated to simulate the thrombolysis of system in blood vessel. Murine tail thrombus model is also built to evaluate thrombolysis in vivo. Consequently, localized hyperthermia is validated to possess an effective enhancement for thrombolysis. Therefore, according to the results, the fabricated system demonstrates two aspects of potential superiority: controlled uPA release for reducing risk of side effects, and hyperthermia‐enhanced thrombolysis locally for decreasing drug dosage. Assisted with thermal thrombolysis, the present formulated system shows a high efficiency, on‐demand drug release, and thus a safer protocol for thrombolytic therapy, which fits the developing trends of precision medicine.
- 3 July 2017
- Published by Taylor & Francis in Molecular Crystals and Liquid Crystals
- Vol. 651 (1) , 235-242
Stability enhancement in InGaZnO thin-film transistor with a novel Al 2 O 3 /HfO 2 /Al 2 O 3 as gate insulator
This work reports an efficient route for enhancing the stability of amorphous InGaZnO (a-IGZO) thin film transistors (TFTs). It is clearly observed that the off-current in IGZO-TFT decreases by using a novel Al2O3/HfO2/Al2O3 gate insulator. Temperature-stress measurement were carried out to investigate the stability and the parameters related to activation energy (EA) and density-of-states (DOS). The improved electrical properties are attributed to the suppression of leakage current and a lower trapping density at the channel-insulator interface. The results showed that temperature stability and electrical properties enhancements in a-IGZO thin film transistors can probably be ascribed to the smaller DOS.
- 3 July 2017
- Published by Taylor & Francis in Molecular Crystals and Liquid Crystals
- Vol. 651 (1) , 235-242
Stability enhancement in InGaZnO thin-film transistor with a novel Al 2 O 3 /HfO 2 /Al 2 O 3 as gate insulator
This work reports an efficient route for enhancing the stability of amorphous InGaZnO (a-IGZO) thin film transistors (TFTs). It is clearly observed that the off-current in IGZO-TFT decreases by using a novel Al2O3/HfO2/Al2O3 gate insulator. Temperature-stress measurement were carried out to investigate the stability and the parameters related to activation energy (EA) and density-of-states (DOS). The improved electrical properties are attributed to the suppression of leakage current and a lower trapping density at the channel-insulator interface. The results showed that temperature stability and electrical properties enhancements in a-IGZO thin film transistors can probably be ascribed to the smaller DOS.